miR-29b-3p's Effects on Prostate Cancer

被引:0
|
作者
Zhou Hongyi [1 ]
Yan Zhiqiang [1 ]
Zhu Leilei [1 ]
Li Maolin [1 ]
Shao Jianfeng [1 ]
Hu Qiang [1 ]
Xu Zhouqun [1 ]
机构
[1] Nanjing Med Univ, Dept Urol, Affiliated WuXi Peoples Hosp, Wuxi 214000, Jiangsu, Peoples R China
关键词
MiR-29b-3p; PTEN; AKT; DU145; PC3; PROMOTES CELL-PROLIFERATION; ACTIVATION; CARCINOMA; MIGRATION;
D O I
10.1166/jbt.2022.2964
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Objection: Our research wanted to discuss miR-29b-3p in PCa occurrence and development and relative mechanisms. Methods: Collecting adjacent and cancer tissues from prostate cancer patients and measuring miR-29b-3p expressions by RT-qPCR and ISH assay. Using DU145 and PC3 cell lines which the miR-29b-3p were high expression in our study. Using miR inhibitor to knockdown miR-29b-3p in DU145 and PC3. Using CCK-8 and flow cytometry to measure cell proliferation and cell apoptosis, invasion cell number by transwell and wound healing rate by wound healing assay. The relative proteins expressions were measured using WB assay. p-AKT nuclear levels were evaluated using Cell immunofluorescence test. Using dual-luciferase reporter gene assay to analysis correlation miR-29b-3p and PTEN. Results: miR-29b-3p gene significantly increased. miR-29b-3p knockdown had effects to depress cell proliferation, increase cell apoptosis, depress invasion cells number and wound healing rates. PTEN proteins were significantly up-regulation and p-AKT and MMP-9 proteins expressions were significantly down-regulation (P < 0.001, respectively). And p-AKT nuclear volume were significantly depressed. And miR-29b-3p could target PTEN. Conclusion: miR-29b-3p played an oncology gene in prostate cancer via regulation PTEN/AKT pathway in vitro study.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 50 条
  • [21] MiR-29b-3p promotes chondrocyte apoptosis and facilitates the occurrence and development of osteoarthritis by targeting PGRN
    Chen, Lingqiang
    Li, Qin
    Wang, Jing
    Jin, Song
    Zheng, Hongmei
    Lin, Jun
    He, Fang
    Zhang, Hong
    Ma, Sha
    Mei, Jian
    Yu, Juan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (12) : 3347 - 3359
  • [22] LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p
    Xue Zou
    Jialiang Wang
    Li Tang
    Qian Wen
    In Vitro Cellular & Developmental Biology - Animal, 2019, 55 : 482 - 490
  • [23] Overexpression of MiR-29b-3p Inhibits Atrial Remodeling in Rats by Targeting PDGF-B Signaling Pathway
    Lv, Xiangwei
    Lu, Pan
    Hu, Yisen
    Xu, Tongtong
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [24] 针刺对脑缺血再灌注损伤大鼠海马组织miR-29a-3p、miR-29b-3p表达的影响
    王瑶
    江姗姗
    谢灿明
    向静
    唐红
    汪红娟
    李展富
    刘晓月
    陈楚淘
    田浩梅
    时珍国医国药, 2024, 35 (02) : 485 - 488
  • [25] XSSJS']JS inhibits hepatic fibrosis by promoting the miR-29b-3p/VEGFA axis in vitro and in vivo
    Zhang, Tianyao
    Yang, Yu
    Wang, Baojia
    Wang, Long
    Wang, Dong
    Cao, Ning
    Shi, Jinyu
    BIOSCIENCE REPORTS, 2022, 42 (02)
  • [26] MiR-29b-3p在膀胱癌化疗耐受机制中的作用
    李洋
    梁瑜
    皖南医学院学报, 2015, 34 (02) : 117 - 121
  • [27] Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p
    Ni, Huaner
    Li, Weifeng
    Ying Zhuge
    Xu, Shuang
    Wang, Yue
    Chen, Yang
    Shen, Gu
    Wang, Fang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 292 : 188 - 196
  • [28] Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats
    Yun-Qiang Wan
    Jian-Guo Feng
    Mao Li
    Mao-Zhou Wang
    Li Liu
    Xueru Liu
    Xiao-Xia Duan
    Chun-Xiang Zhang
    Xiao-Bin Wang
    Experimental & Molecular Medicine, 2018, 50 : 1 - 14
  • [29] miR-29b-3p regulates cardiomyocytes pyroptosis in CVB3-induced myocarditis through targeting DNMT3A
    Wang, Ya
    Zhang, Zhengyang
    Li, Hui
    Wang, Min
    Qiu, Yuting
    Lu, Lili
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2024, 29 (01)
  • [30] Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1
    Han, Junyu
    Zhang, Ziguan
    Zhang, Zhonghe
    Yang, Shuyu
    FRONTIERS IN PHARMACOLOGY, 2022, 13